GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Isis Pharmaceuticals, Inc. (ISIS) [hlAlert]

Isis Pharmaceuticals, Inc. (Isis) is engaged in antisense technology, exploiting a drug discovery platform to create a pipeline of drugs. The Company operates in a two principal segments: Drug Discovery and Development and Regulus Therapeutics Inc. Within the Drug Discovery and Development segment, its
drug discovery platform enables the Company to identify drugs, providing potential targets to treat a range of diseases. As of December 31, 2008, the Company has 19 drugs in development. Its partners are licensed to develop, with the Company?s support, 15 of these 19 drugs. The Company and Alnylam established Regulus Therapeutics Inc. as a company focused on the discovery, development and commercialization of microRNA therapeutics. In January 2009, the Company sold its subsidiary, Ibis Biosciences, Inc. to Abbott Molecular Inc. (AMI), a wholly owned subsidiary of Abbott Laboratories.
.
( Total: 25 Current Stock Recommendations )
Isis Pharmaceuticals, Inc.   (25)
Sell Hold 48% Buy 48%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Show  

Date (ET)MemberRatingYTD
Gains
 
9/14/2007  
Buy
  
9/24/2007  
Buy
  
10/8/2007  
Buy
  
10/9/2007  
Buy
  
10/11/2007  
Buy
  
1/2/2008  
Buy
  
1/7/2008  
Buy
  
4/18/2008  
Hold
  
5/9/2008  
Hold
  
1/9/2009  
Buy
  
2/10/2009  
Hold
  
7/29/2009  
Buy
  
11/18/2009  
Buy
  
4/6/2010  
Hold
  
8/5/2010  
Hold
  
8/5/2010  
Hold
  
7/19/2012  
Sell
  
7/30/2012  
Buy
  
10/17/2012  
Hold
  
9/4/2013  
Hold
  
10/4/2013  
Hold
  
11/27/2013  
Hold
  
2/20/2014  
Hold
  
3/2/2015  
Hold
  
11/10/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy